Editorial: Novel clinical applications of extracellular vesicles

Frontiers in Immunology

Volumn 6, Issue JUL, 2015, Pages

  Sáenz Cuesta, Matías ^a   Mittelbrunn, María ^b   Otaegui, David ^a  

^a BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Biomarkers; Clinical application; Exosomes; Extracellular vesicles; Immunotherapy; Microvescicles; Omics technologies; Protocol standardization

Indexed keywords

ANTIGEN PRESENTATION; APOPTOSIS; APOPTOTIC BODY; CANCER IMMUNOTHERAPY; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL ORGANELLE; DEGENERATIVE DISEASE; DENDRITIC CELL; EDITORIAL; EXOSOME; HUMAN; IMMUNOLOGY; IMMUNOPATHOLOGY; INNATE IMMUNITY; MICROVESICLES; NEOPLASM; TUMOR GROWTH;

EID: 84938509862     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00381     Document Type: Editorial

References (13)

1. Yáñez-Mó M, Siljander PR-M, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 4:27066. doi: 10.3402/jev.v4.27066
2. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol (2009) 9(8):581-93. doi:10.1038/nri2567
3. Lee TH, D'Asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J. Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular "debris". Semin Immunopathol (2011) 33(5):455-67. doi:10.1007/s00281-011-0250-3
4. Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol (2014) 14(3):195-208. doi:10.1038/nri3622
5. Fleury A, Martinez MC, Le Lay S. Extracellular vesicles as therapeutic tools in cardiovascular diseases. Front Immunol (2014) 5:370. doi:10.3389/fimmu.2014.00370
6. De Toro J, Herschlik L, Waldner C, Mongini C. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol (2015) 6:203. doi:10.3389/fimmu.2015.00203
7. Benito-Martin A, Di Giannatale A, Ceder S, Peinado H. The new deal: a potential role for secreted vesicles in innate immunity and tumor progression. Front Immunol (2015) 6:66. doi:10.3389/fimmu.2015.00066
8. Carvalho J, Oliveira C. Extracellular vesicles-powerful markers of cancer evolution. Front Immunol (2015) 5:685. doi:10.1038/nrc3498
9. Gámez-Valero A, Lozano-Ramos SI, Bancu I, Lauzurica-Valdemoros R, Borràs FE. Urinary extracellular vesicles as source of biomarkers in kidney diseases. Front Immunol (2015) 6:6. doi:10.3389/fimmu.2015.00006
10. Sáenz-Cuesta M, Arbelaiz A, Oregi A, Irizar H, Osorio-Querejeta I, Muñoz-Culla M, et al. Methods for extracellular vesicles isolation in a hospital setting. Front Immunol (2015) 6:50. doi:10.3389/fimmu.2015.00050
11. Aiastui A. Should cell culture platforms move towards EV therapy requirements?. Front Immunol (2015) 6:8. doi:10.3389/fimmu.2015.00008
12. Palomo L, Casal E, Royo F, Cabrera D, Van-Liempd S, Falcon-Perez JM. Considerations for applying metabolomics to the analysis of extracellular vesicles. Front Immunol (2014) 5:651. doi:10.3389/fimmu.2014.00651
13. Romagnoli GG, Zelante BB, Toniolo PA, Migliori IK, Barbuto JAM. Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets. Front Immunol (2015) 5:692. doi:10.3389/fimmu.2014.00692